As we age, our eye’s crystalline lens naturally loses its elasticity. This loss in elasticity causes a progressively reduced ability to focus on near objects, a condition known as presbyopia.
Most commonly, patients turn to reading glasses to their improve near vision. Although helpful for activities such as reading a book or dialing a telephone number, reading glasses can be inconvenient as they do not help with distance vision and often need to be removed to see far away.
A study is currently underway to evaluate the safety and efficacy of the Presbia Flexivue Microlens™, a new investigational treatment for presbyopia. If you are interested in reducing your dependency on reading glasses, learn more about the Presbia Flexivue Microlens™ clinical trial below.
As new clinical research study, this clinical trial is looking to recruit adults who are interested in reducing their dependency on reading glasses. The experimental study will evaluate patients’ improvement in near vision through the insertion of a small, thin implant.
The Presbia® inlay is made of material similar to a soft contact lens, and the investigational treatment does not require the removal of any eye tissue. The Presbia Flexivue Microlens™ Technology uses a refractive inlay, enabling the corrective power to potentially be removable and replaceable should a patient’s presbyopia advance and require a new prescription.
Qualified participants must be between 45-60 years old, wear reading glasses, have good distance vision in both eyes, and be in good overall health.
For additional inclusion criteria and more information about the study, such as how to apply, please visit Tossyourreaders.com and Presbia.com.
If you would like to learn more about presbyopia treatment options available at our practice, or to schedule a consultation with one of our eye doctors, please contact us today.
The information about the Presbia Flexivue Microlens™ clinical research study is not intended to provide medical advice. Make sure to always consult your doctor for medical advice and treatment prior to taking action.
Caution: Investigational device. Limited by United States federal law to investigational use.
Gordon Schanzlin New Vision Institute can help bring the cost of treatment into your budget. We work with CareCredit®, a reputable healthcare financing company that offers interest-free and extended payment plans to qualified applicants.
Learn More
